TuisCOR • NYSE
add
Cencora Inc
Vorige sluiting
$237,83
Dagwisseling
$235,76 - $239,29
Jaarwisseling
$214,77 - $253,27
Markkapitalisasie
10,44 mjd USD
Gemiddelde volume
1,18 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 79,05 mjd | 14,69% |
Bedryfskoste | 1,74 mjd | 6,54% |
Netto inkomste | 3,38 m | -99,04% |
Netto winsgrens | 0,00 | -100,00% |
Wins per aandeel | 3,34 | 16,78% |
EBITDA | 982,37 m | 13,78% |
Effektiewe belastingkoers | 94,04% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,13 mjd | 20,86% |
Totale bates | 67,10 mjd | 7,26% |
Totale aanspreeklikheid | 66,31 mjd | 7,15% |
Totale ekwiteit | 786,74 m | — |
Uitstaande aandele | 193,28 m | — |
Prys om te bespreek | 71,85 | — |
Opbrengs op bates | 2,63% | — |
Opbrengs op kapitaal | 25,89% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 3,38 m | -99,04% |
Kontant van bedrywe | 1,00 mjd | -45,24% |
Kontant van beleggings | -241,88 m | -31,86% |
Kontant van finansiering | -957,26 m | -135,19% |
Netto kontantverandering | -178,52 m | -114,82% |
Beskikbare kontantvloei | 1,28 mjd | -40,45% |
Meer oor
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It is considered one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products as well as home healthcare supplies and equipment. Wikipedia
Gestig
1871
Webwerf
Werknemers
44 000
